![Christopher Peetz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Peetz
Fondateur chez
MIRUM PHARMACEUTICALS, INC.
Fortune : 50 M $ au 30/06/2026
Profil
Christopher Peetz is the founder of Mirum Pharmaceuticals, Inc., founded in 2018, serving as Chief Executive Officer & Director.
Current jobs include Chief Executive Officer at Satiogen Pharmaceuticals, Inc. and Independent Director at Arcutis Biotherapeutics, Inc. starting in 2026.
Former jobs include Chief Executive Officer at Flashlight Therapeutics, Inc. from 2017 to 2019; Senior Director-Corporate Development & Strategy at Onyx Pharmaceuticals, Inc. from 2007 to 2012; Independent Director at Alpine Immune Sciences, Inc. from 2018 to 2024; Principal at TerraVia Holdings, Inc.; Vice President-Finance & Development at SillaJen Biotherapeutics, Inc. from 2012 to 2014; and Chief Financial Officer & Head-Development at Tobira Therapeutics, Inc. from 2014 to 2016.
Education includes undergraduate studies at Washington University in St. Louis and an MBA from Stanford Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/07/2026 | 381 809 ( 0,63% ) | 45 M $ | 30/06/2026 | |
| 15/07/2026 | 191 815 ( 0,15% ) | 5 M $ | 30/06/2026 |
Postes actifs de Christopher Peetz
| Sociétés | Poste | Début |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Fondateur | 07/05/2018 |
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/07/2026 |
Satiogen Pharmaceuticals, Inc.
 Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Directeur Général | - |
Anciens postes connus de Christopher Peetz
| Sociétés | Poste | Fin |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Directeur/Membre du Conseil | 20/05/2024 |
Flashlight Therapeutics, Inc.
 Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for unmet medical needs | Directeur Général | 01/05/2019 |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Directeur Financier/CFO | 01/12/2016 |
| TOBIRA THERAPEUTICS INC | Directeur Financier/CFO | 01/12/2016 |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Corporate Officer/Principal | 01/03/2014 |
Formation de Christopher Peetz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
TerraVia Holdings, Inc.
 TerraVia Holdings, Inc. Household/Personal CareConsumer Non-Durables Manufactures and sells food, nutrition and specialty ingredients from algae | Consumer Non-Durables |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Commercial Services |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Commercial Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Flashlight Therapeutics, Inc.
Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for unmet medical needs | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
